Short answer · Medically reviewed summary · Last updated: 2026-05-08
Carcinoid syndrome is a paraneoplastic condition caused by the systemic release of vasoactive substances, such as serotonin, from neuroendocrine tumors (NETs) that have metastasized, usually to the liver. It occurs when these substances bypass the liver’s metabolic breakdown and enter the general circulation, leading to characteristic symptoms like flushing and diarrhea. What triggers Carcinoid Syndrome? The primary cause of carcinoid syndrome is the presence of neuroendocrine tumors that secrete excess hormones directly into the bloodstream.
1 people with Carcinoid Syndrome have shared their first-person experience on this question at DiseaseMaps.
Which are the causes of Carcinoid Syndrome?
Causes of Carcinoid Syndrome explained: genetic and environmental factors, reviewed against medical sources, plus patient perspectives.
Carcinoid syndrome is a paraneoplastic condition caused by the systemic release of vasoactive substances, such as serotonin, from neuroendocrine tumors (NETs) that have metastasized, usually to the liver. It occurs when these substances bypass the liver’s metabolic breakdown and enter the general circulation, leading to characteristic symptoms like flushing and diarrhea.
What triggers Carcinoid Syndrome?
The primary cause of carcinoid syndrome is the presence of neuroendocrine tumors that secrete excess hormones directly into the bloodstream. In most cases, these tumors originate in the gastrointestinal tract or lungs. When these tumors spread (metastasize) to the liver, the liver can no longer neutralize the hormones before they reach the rest of the body, triggering the clinical manifestations of carcinoid syndrome. Think of the liver as a filter; when the "filter" is overwhelmed by tumor cells, the hormones "leak" into the systemic circulation.
Is there a genetic component to Carcinoid Syndrome?
While most cases of the tumors underlying carcinoid syndrome are sporadic, meaning they occur by chance, some are associated with inherited genetic syndromes. These include Multiple Endocrine Neoplasia type 1 (MEN1), Neurofibromatosis type 1 (NF1), and Tuberous Sclerosis Complex. In these instances, the genetic mutation predisposes an individual to developing neuroendocrine tumors, which may eventually lead to carcinoid syndrome if they become metastatic.
Are there specific risk factors involved?
It is important to distinguish between the cause (the hormone-secreting tumor) and risk factors. Risk factors for developing the underlying tumors include:
- Family History: Having a first-degree relative with a neuroendocrine tumor or associated genetic syndrome.
- Age: The risk increases with age, with most diagnoses occurring between the ages of 50 and 60.
- Pre-existing conditions: Conditions like atrophic gastritis or pernicious anemia may increase the risk of gastric neuroendocrine tumors.
What does current research tell us?
Current research into carcinoid syndrome focuses on the molecular pathways that allow these tumors to overproduce serotonin and tachykinins. Scientists are investigating why some tumors remain dormant while others become aggressive. At DiseaseMaps.org, 49 community members are sharing their experiences, helping researchers better understand the heterogeneous nature of this condition.
Next steps
- Consult an oncologist or endocrinologist specializing in neuroendocrine tumors.
- Request genetic counseling if you have a strong family history of endocrine tumors.
- Join the DiseaseMaps.org community to connect with others managing carcinoid syndrome.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases (GARD) Information Center - Carcinoid Syndrome
- Orphanet: Neuroendocrine tumor of the gastrointestinal tract
- North American Neuroendocrine Tumor Society (NANETS) guidelines
- PubMed: Pathophysiology of the Carcinoid Syndrome
Posted Sep 14, 2017 by Vickie 2000
